Medicine
Baqsimi 3 mg powder
Baqsimi 3 mg powder is a prescription medicine containing Glucagon for nasal use, marketed by Amphastar Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at temperatures up to 86°F (30°C) in the shrink wrapped tube provided.
Key facts
- Active ingredient (INN)
- Glucagon
- Brand
- Baqsimi
- Strength
- 3 mg
- Dosage form
- Powder
- Route
- Nasal
- Packs
- 1 tube, 2 tubes
- Marketing authorisation holder
- Amphastar Pharmaceuticals
- Manufacturers
- Amphastar PharmaceuticalsSportpharm
- Origin register
- US FDA, United States
- Storage
- Store at temperatures up to 86°F (30°C) in the shrink wrapped tube provided.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H04AA01 Glucagon
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 July 2019
- Identifiers
- RxCUI 2180666, 2180671DailyMed set ID f1f5df9b-872f-44e5-a18f-f0b68e7e9254, 32ba41fa-4158-40af-8cb2-03693c248994NDC 0548-8352, 85766-212, 0548-8351Application NDA210134
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 1 bottle, unit-dose in 1 tube / 1 powder in 1 bottle, unit-dose | 0548-8351-01 | Amphastar Pharmaceuticals | 15 March 2024 |
| 2 tube in 1 carton / 1 bottle, unit-dose in 1 tube / 1 powder in 1 bottle, unit-dose | 0548-8352-02 | Amphastar Pharmaceuticals | 7 February 2024 |
| 1 tube in 1 carton / 1 bottle, unit-dose in 1 tube / 1 powder in 1 bottle, unit-dose | 85766-212-03 | Sportpharm | 19 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Glucagon
Clinical summary
Glucagon is an antihypoglycemic agent. It is available as injection, kits and powder for intravenous, subcutaneous and intramuscular use. MedsAcross supplies Glucagon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlucagonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glucagon prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
- Baqsimi: European public assessment report (EPAR) · European Medicines Agency
- Ogluo: European public assessment report (EPAR) · European Medicines Agency
Need Baqsimi 3 mg powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.